PUBLICATION

Tryptophan Hydroxylase 2 Deficiency Modifies the Effects of Fluoxetine and Pargyline on the Behavior, 5-HT- and BDNF-Systems in the Brain of Zebrafish (Danio rerio)

Authors
Evsiukova, V.S., Bazovkina, D., Bazhenova, E., Kulikova, E.A., Kulikov, A.V.
ID
ZDB-PUB-211214-23
Date
2021
Source
International Journal of Molecular Sciences   22(23): (Journal)
Registered Authors
Keywords
BDNF, antidepressant resistance, behavior, brain, serotonin, translational study, tryptophan hydroxylase 2, zebrafish
MeSH Terms
  • Animals
  • Antidepressive Agents/pharmacology
  • Behavior, Animal/drug effects*
  • Brain/drug effects*
  • Brain/enzymology
  • Brain/metabolism
  • Brain-Derived Neurotrophic Factor/metabolism*
  • Disease Models, Animal
  • Fluoxetine/pharmacology*
  • Monoamine Oxidase Inhibitors/pharmacology
  • Pargyline/pharmacology*
  • Selective Serotonin Reuptake Inhibitors/pharmacology
  • Serotonin/metabolism*
  • Tryptophan Hydroxylase/deficiency*
  • Tryptophan Hydroxylase/metabolism
  • Zebrafish
  • Zebrafish Proteins/deficiency*
  • Zebrafish Proteins/metabolism
PubMed
34884655 Full text @ Int. J. Mol. Sci.
Abstract
The mechanisms of resistance to antidepressant drugs is a key and still unresolved problem of psychopharmacology. Serotonin (5-HT) and brain-derived neurotrophic factor (BDNF) play a key role in the therapeutic effect of many antidepressants. Tryptophan hydroxylase 2 (TPH2) is the rate-limiting enzyme in 5-HT synthesis in the brain. We used zebrafish (Danio rerio) as a promising model organism in order to elucidate the effect of TPH2 deficiency caused by p-chlorophenylalanine (pCPA) on the alterations in behavior and expression of 5-HT-related (Tph2, Slc6a4b, Mao, Htr1aa, Htr2aa) and BDNF-related (Creb, Bdnf, Ntrk2a, Ngfra) genes in the brain after prolonged treatment with two antidepressants, inhibitors of 5-HT reuptake (fluoxetine) and oxidation (pargyline). In one experiment, zebrafish were treated for 72 h with 0.2 mg/L fluoxetine, 2 mg/L pCPA, or the drugs combination. In another experiment, zebrafish were treated for 72 h with 0.5 mg/L pargyline, 2 mg/L pCPA, or the drugs combination. Behavior was studied in the novel tank diving test, mRNA levels were assayed by qPCR, 5-HT and its metabolite concentrations were measured by HPLC. The effects of interaction between pCPA and the drugs on zebrafish behavior were observed: pCPA attenuated "surface dwelling" induced by the drugs. Fluoxetine decreased mRNA levels of Tph2 and Htr2aa genes, while pargyline decreased mRNA levels of Slc6a4b and Htr1aa genes. Pargyline reduced Creb, Bdnf and Ntrk2a genes mRNA concentration only in the zebrafish treated with pCPA. The results show that the disruption of the TPH2 function can cause a refractory to antidepressant treatment.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping